Seeking Alpha
 

PerkinElmer, Inc. (PKI)

- NYSE
Show Summaries  |  Hide Summaries
  • Jan. 25, 2013, 4:34 PM
    PerkinElmer, Inc. (PKI) declares $0.07/share quarterly dividend, in line with previous. Forward yield 0.79%. For shareholders of record Apr. 19. Payable May 10. Ex-div date Apr. 17. (PR)
    | Comment!
  • Nov. 12, 2012, 4:28 PM
    PerkinElmer (PKI) says it's completed the acquisition of Shanghai Haoyuan Biotech, a China-based infectious disease diagnostics company, for $38M in cash plus future consideration based on the achievement of revenue-based targets. PKI says the deal should be immaterial to adjusted earnings for the remainder of 2012 and 2013 and accretive beginning in 2014.
    | Comment!
  • Oct. 25, 2012, 4:50 PM
    More on Perkin Elmer (PKI): Q3 beats across the board on strong revenue growth out of its human-health focused segment. Net profit declined 19% however, due largely to lower contributions from businesses that the company has sold. For FY12, the company raises its per-share earnings estimate to $2.05 to $2.07, up from its prior estimate for $2 to $2.05, and reiterated its forecast for organic revenue growth.
    | Comment!
  • Oct. 25, 2012, 4:40 PM
    PerkinElmer (PKI): Q3 EPS of $0.45 beats by $0.01. Revenue of $509.6M (+13% Y/Y) beats by $4M. (PR)
    | Comment!
  • Oct. 24, 2012, 6:43 PM
    PerkinElmer (PKI) declares $0.07/share quarterly dividend, in line with previous. Forward yield 0.99%. For shareholders of record Jan 18. Payable Feb 08. Ex-div date jan 16. (PR)
    | Comment!
  • Aug. 3, 2012, 12:55 PM
    Shares of PerkinElmer (PKI +9%) rally after beating on its Q2 EPS target this morning. Net earnings increased 13% Y/Y on double-digit revenue growth in its health care business and stronger margins. Revenue from its human health business rose 18%, while its environmental health segment saw an anemic 1.2% increase. Gross margins also rose to 45.8% from 43.7%.
    | Comment!
  • Aug. 2, 2012, 6:21 PM
    PerkinElmer (PKI): Q2 EPS of $0.53 beats by $0.06. Revenue of $532M (+9% Y/Y) misses by $5M. (PR)
    | Comment!
  • Jul. 27, 2012, 4:16 PM
    PerkinElmer (PKI) declares $0.07/share quarterly dividend, in line with previous. Forward yield 1.09%. For shareholders of record Oct 19. Payable Nov 09. Ex-div date Oct 05. (PR)
    | Comment!
  • Jun. 19, 2012, 3:53 PM
    PerkinElmer (PKI +3%) holds on to gains late in the day after being upgraded to Conviction Buy on valuation at Goldman this morning, citing its margin expansion potential and low NIH funding. Price target is $34.
    | Comment!
  • Apr. 26, 2012, 6:12 PM
    PerkinElmer (PKI): Q1 EPS of $0.43 beats by $0.02. Revenue of $511M (+15.7% Y/Y) beats by $3M. (PR)
    | Comment!
  • Feb. 3, 2012, 2:27 PM
    Impressed by PerkinElmer's (PKI +7%) "shock and awe" Q4 results, Jefferies raises its earnings estimates and price target to $27 from $23. "Our focus remains on PKI's ability to consistently drive OP margin expansion," the firm says. The provider of equipment for genetic screening and drug research forecasts 2012 EPS of $1.98-$2.04 vs. $1.91 consensus.
    | Comment!
  • Feb. 3, 2012, 9:46 AM
    Shares of PerkinElmer (PKI +4.4%) gain steam off of a Q4 earnings beat and the firm's improved outlook for 2012. The company now sees EPS of $1.98-$2.04, higher than the consensus estimate mark of analysts of $1.92.
    | Comment!
  • Feb. 2, 2012, 4:29 PM
    PerkinElmer (PKI): Q4 EPS of $0.62 beats by $0.11. Revenue of $554.7M (+14.9% Y/Y) beats by $17M. Shares +4% AH. (PR)
    | Comment!
  • Feb. 2, 2012, 12:10 AM
    Notable earnings after Thursday's close: APKT, CAVM, CFN, CPT, EW, GILD, GNW, MCHP, NLY, NVLS, PFG, PKI, SFSF, SUN, SXC, TTWO, VRTX, WYNN
    | Comment!
  • Feb. 1, 2012, 5:35 PM
    Notable earnings after Thursday's close: APKT, CAVM, CFN, CPT, EW, GILD, GNW, MCHP, NLY, NVLS, PFG, PKI, SFSF, SUN, TTWO, VRTX, WYNN
    | Comment!
  • Nov. 3, 2011, 4:39 PM
    PerkinElmer (PKI): Q3 EPS of $0.24 misses by $0.15. Revenue of $454M (+4% Y/Y) misses by $16M. Shares -1.8% AH. (PR)
    | Comment!
Visit Seeking Alpha's
PKI vs. ETF Alternatives
Company Description
PerkinElmer Inc is a provider of technology, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets.